GLP-1 Drugs Like Ozempic Linked to Higher Bone Fracture & Tendon Injury Risk
A major new study published in The Washington Post reveals that GLP-1 receptor agonists â including Ozempic, Wegovy, and Mounjaro â significantly increase the risk of bone fractures (up 40% after 12 months) and tendon injuries (up 65% in users over 50). With over 25 million Americans on these medications, the FDA is reviewing additional safety warnings. This calculator helps you assess your personal risk profile based on age, weight loss, duration, and lifestyle factors.
About This Calculator: GLP-1 Ozempic Health Risk
Why: Over 25 million Americans take GLP-1 drugs for weight loss and diabetes. A major Washington Post study found significant bone, tendon, and muscle risks. Most users don't know their personal risk profile. This calculator helps you understand your risk based on age, weight loss, duration, and protective factors.
How: Enter your age, weight, duration on GLP-1, and (in advanced mode) medication type, dosage, weight lost, activity level, bone conditions, exercise frequency, and supplements. The calculator applies study-based modifiers for bone fracture (+40% per year), tendon injury (+65% for 50+), muscle loss (30-40% without resistance training), and GI risk. Protective factors (exercise, calcium, resistance training) reduce risk.
ð Quick Examples â Click to Load
â ïļ Not medical advice. This tool is for educational purposes only. Always consult your healthcare provider.
â ïļFor educational and informational purposes only. Verify with a qualified professional.
GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Zepbound) are widely prescribed for weight loss and diabetes. A major Washington Post study (March 2026) revealed significant health risks: bone fracture risk increases 40% after 12+ months, tendon injuries (especially Achilles) rise 65% in users over 50, and rapid weight loss accelerates bone density loss. Over 25 million Americans are on these medications. The FDA is reviewing additional safety warnings. This calculator helps you assess your personal risk based on age, weight loss, duration, and lifestyle factors.
Sources: Washington Post, NIH, FDA, Endocrine Society.
Key Study Findings (Washington Post)
- âĒ Bone fracture risk increases 40% after 12+ months of GLP-1 use
- âĒ Tendon injuries (especially Achilles) rise 65% in users over 50
- âĒ Rapid weight loss (>15% body weight) accelerates bone density loss
- âĒ 30-40% of weight lost without resistance training is muscle mass
- âĒ GI side effects: nausea 30-44%, vomiting 10-15%, diarrhea 15-20%
Bone Health and GLP-1
Mechanism
GLP-1 drugs affect bone turnover. Rapid weight loss reduces mechanical loading on bones. Combined with potential effects on calcium absorption, this can accelerate bone density loss.
Risk Factors
Longer duration, higher dosage, >15% weight lost, female gender, existing osteopenia/osteoporosis, and sedentary lifestyle all increase bone fracture risk.
Protection
Weight-bearing exercise (-30% risk), calcium/vitamin D (-20%), and slower weight loss (1-2 lbs/week) can mitigate bone loss.
Tendon Injury Risks
Achilles tendon injuries are particularly common in GLP-1 users over 50. The risk increases with duration of use. Theories include changes in collagen metabolism or rapid weight loss affecting tendon load. Warm up properly, avoid sudden high-impact movements, and increase activity gradually. Stretching and strength training may help.
Muscle Loss Prevention
Without resistance training, 30-40% of weight lost on GLP-1 drugs is muscle. With 3+ resistance training sessions per week, muscle loss drops to 15-20%. Prioritize protein (1.2-1.6 g/kg), strength training, and avoid very low-calorie diets. Sarcopenia (muscle loss) accelerates with age â older users should be especially vigilant.
GI Side Effects
Nausea (30-44%), vomiting (10-15%), and diarrhea (15-20%) are dose-dependent. Starting at a low dose and titrating slowly can reduce GI symptoms. Taking medication with food, eating smaller meals, and avoiding fatty foods may help. Most side effects improve over time.
Protective Strategies
Comparison of GLP-1 Drugs
| Drug | Active Ingredient | Route |
|---|---|---|
| Ozempic | Semaglutide | Weekly injection |
| Wegovy | Semaglutide | Weekly injection |
| Mounjaro | Tirzepatide | Weekly injection |
| Zepbound | Tirzepatide | Weekly injection |
| Rybelsus | Semaglutide | Daily pill |
Frequently Asked Questions
Do GLP-1 drugs cause bone loss?
Yes. A major Washington Post study (March 2026) found that GLP-1 receptor agonists like Ozempic and Wegovy increase bone fracture risk by up to 40% after 12 months of use. Rapid weight loss accelerates bone density loss, especially when more than 15% of body weight is lost. Women and those with existing osteopenia or osteoporosis face higher risk.
How to protect bones on Ozempic?
Exercise (especially weight-bearing and resistance training) can reduce bone risk by up to 30%. Calcium and vitamin D supplementation may reduce risk by about 20%. Aim for 3+ resistance training sessions per week. Avoid rapid weight loss when possible â losing more than 1-2 lbs per week increases bone stress.
What is the tendon injury risk by age on GLP-1 drugs?
The Washington Post study found tendon injuries (especially Achilles) rise 65% in GLP-1 users over 50, compared to 25% in younger users. Base annual tendon injury risk is about 2%; GLP-1 use amplifies this. Longer duration on medication increases risk. Stretching, gradual activity increases, and avoiding sudden high-impact movements can help.
How can I prevent muscle loss on GLP-1?
Without resistance training, 30-40% of weight lost on GLP-1 drugs is muscle mass. With 3+ resistance training sessions per week, muscle loss drops to 15-20%. Prioritize protein intake (1.2-1.6 g/kg body weight) and strength training. Avoid crash diets or very low-calorie approaches that accelerate muscle catabolism.
Which GLP-1 drug has the lowest bone risk?
Current data does not show significant differences in bone risk between Ozempic, Wegovy, Mounjaro, and Zepbound. All are GLP-1 receptor agonists with similar mechanisms. Risk is driven more by duration of use, amount of weight lost, age, and baseline bone health than by the specific medication.
Should I take calcium with Ozempic?
Yes. Calcium (1,200 mg/day for women 50+, 1,000 mg for others) and vitamin D (600-800 IU) are recommended for GLP-1 users to support bone health. Take calcium with meals for better absorption. Discuss supplementation with your doctor, especially if you have kidney issues or take other medications.
Sources
â ïļ Medical Disclaimer: This calculator is for educational and informational purposes only. It is NOT medical advice. The risk estimates are based on published study data and simplified models. Individual risk varies. Always consult a qualified healthcare provider before making decisions about GLP-1 medications, supplements, or lifestyle changes. Do not stop or start any medication without medical supervision.